ABT-957 in Subjects with Mild to Moderate Alzheimer's Taking Acetylcholinesterase Inhibitors
Language
Undefined
Purpose: To evaluate the safety, tolerability, and pharmacokinetics of ABT-957 in people with mild to moderate Alzheimer's disease.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: chirschman Source Type: clinical trials